Scope
NICE guidance for people over sixteen with low back pain, with or without sciatica, emphasises exclusion of serious pathology, selective imaging, activity and exercise, and restraint in medication and invasive procedures. This summary follows the currently displayed recommendations, including the removal of older psychological-programme recommendations rather than silently carrying those forward.
Written by House with AI assistance · AI-assisted source check 29 October 2026.
This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.
Reassess diagnosis and avoid routine imaging
- Reconsider alternative diagnoses when back pain changes or new symptoms appear, including cancer, infection, trauma and inflammatory disease. Suspected serious pathology needs the relevant specialist pathway rather than management as uncomplicated mechanical pain. [1]
- At the first contact for a new episode, consider a risk-stratification tool to guide shared decisions. Consider simpler reassurance and self-management support when recovery is likely, and more intensive support for a higher risk of poor outcome. [1]
- Do not routinely arrange imaging in a nonspecialist setting. Explain that specialist referral may still not require imaging; in specialist care, consider it only when the result is likely to change management. [1]
Support activity and appropriate exercise
- Provide advice adapted to the patient’s abilities and needs, including explanation of the condition and encouragement to continue normal activity. Promote return to work and everyday activities. [1]
- Consider a group exercise programme for an episode or flare-up, selecting biomechanical, aerobic, mind–body or combined approaches according to the person’s preferences and capabilities. [1]
- Consider manual therapy only as part of a package that also includes exercise. The currently retained recommendation does not support manual therapy as a stand-alone substitute for exercise. [1]
- Do not offer belts, corsets, foot orthotics, rocker-sole shoes or traction for low back pain with or without sciatica. [1]
- Do not offer acupuncture, therapeutic ultrasound, PENS, TENS or interferential therapy for these presentations. [1]
Avoid medicines without overall benefit for sciatica
- Do not offer gabapentinoids, other antiepileptics, oral corticosteroids or benzodiazepines for sciatica because the guideline finds no overall benefit and evidence of harm. Do not use opioids for chronic sciatica. [1]
- If someone already takes opioids, gabapentinoids or benzodiazepines for sciatica, explain ongoing risks and discuss withdrawal problems as part of a shared decision about stopping. The recommendation does not call for abrupt unplanned cessation. [1]
- Recognise limited benefit evidence and potential harm from NSAIDs for sciatica. If used, assess gastrointestinal, hepatic and cardiorenal risks, consider monitoring and gastroprotection, and use the lowest effective dose for the shortest duration. [1]
Use limited analgesic options for low back pain
- Consider an oral NSAID for low back pain after assessing individual toxicity risks. Use appropriate monitoring and gastroprotection, and prescribe the lowest effective dose for the shortest possible period. [1]
- For acute low back pain, consider a weak opioid, with or without paracetamol, only when an NSAID is contraindicated, poorly tolerated or ineffective. Do not routinely use opioids for acute pain or use them for chronic low back pain. [1]
- Do not use paracetamol alone, selective serotonin reuptake inhibitors, serotonin–noradrenaline reuptake inhibitors, tricyclic antidepressants, gabapentinoids or other antiepileptics to manage low back pain. [1]
Restrict interventional treatment to the stated indications
- Do not offer spinal injections for low back pain. Consider radiofrequency assessment for chronic low back pain when nonsurgical treatment has failed, pain is thought to arise from medial-branch-innervated structures, and localised pain is moderate or severe: at least 5 on a visual analogue scale or equivalent at referral. [1]
- For chronic low back pain, perform radiofrequency denervation only after a positive diagnostic medial branch block. Do not make imaging of facet-joint pain a prerequisite for that treatment. [1]
- Consider epidural local anaesthetic and steroid for acute severe sciatica. Do not use epidural injections for neurogenic claudication due to central spinal canal stenosis. [1]
- Consider spinal decompression when nonsurgical treatment has not improved sciatic pain or function and imaging findings fit the symptoms. BMI, smoking and psychological distress should not determine whether a surgical opinion is offered. [1]
- Do not offer spinal fusion for low back pain outside a randomised controlled trial, and do not offer disc replacement for low back pain. [1]
Limitations and use
- NICE removed recommendations 1.2.13 and 1.2.14 in July 2026 after surveillance found they might be outdated; their previous content is not reproduced as a current recommendation.
- This is not the diagnostic or emergency-management pathway for suspected cancer, spinal injury, infection or inflammatory disease. Those conditions require their separate guidance.
- The summary does not provide drug doses, withdrawal schedules or procedural technique.
This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.
Summary sources
- Low back pain and sciatica in over 16s: assessment and management
Selected recommendation material consulted
Publication details
- Issuing organisation
- NICE
- First published
- 30 November 2016
- Publisher’s latest update
- 29 July 2026
- Resource type
- Clinical guideline · House clinical summary
- Source setting
- United Kingdom
Earlier House summaries: low back pain and sciatica nice
The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.